These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11328907)

  • 1. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
    Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
    Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.
    Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G
    Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily haemodialysis improves indices of protein glycation.
    Floridi A; Antolini F; Galli F; Fagugli RM; Floridi E; Buoncristiani U
    Nephrol Dial Transplant; 2002 May; 17(5):871-8. PubMed ID: 11981076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
    Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
    Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in serum pentosidine levels of ESRD patients during polysulfone haemodialysis.
    Stein G; Franke S; Sperschneider H; Vienken J; Ueda Y; Miyata T; Kurokawa K
    Nephrol Dial Transplant; 1999 Jun; 14(6):1606-8. PubMed ID: 10383042
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
    Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
    Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
    Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
    Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pentosidine levels in uremic patients before and after hemodialysis.
    Takahashi M; Kushida K; Ishihara C; Denda M; Inoue T
    Scand J Urol Nephrol; 1995 Jun; 29(2):131-4. PubMed ID: 7569788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
    Misselwitz J; Franke S; Kauf E; John U; Stein G
    Pediatr Nephrol; 2002 May; 17(5):316-21. PubMed ID: 12042886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients.
    Słowik-Zyłka D; Safranow K; Dziedziejko V; Ciechanowski K; Dziewanowski K; Chlubek D
    Pol Arch Med Wewn; 2009 Oct; 119(10):614-20. PubMed ID: 19847136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
    Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
    Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
    Busch M; Schwenzky A; Franke S; Stein G; Wolf G
    Blood Purif; 2012; 34(1):3-9. PubMed ID: 22699860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of medium cut-off membranes on Pentosidine and N-(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients.
    Koç NS; Yeter H; Yıldırım T; Erdem Y; Yılmaz R
    Ther Apher Dial; 2024 Aug; 28(4):591-598. PubMed ID: 38572624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.